| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/12/2011 | WO2011056124A1 Her3 binding polypeptides |
| 05/12/2011 | WO2011056060A2 Recombinant matrix protein of nipah virus |
| 05/12/2011 | WO2011055366A1 Mo-1 conditional knock-out non-human animal and uses thereof |
| 05/12/2011 | WO2011055210A1 Hot spring bacterial strain bkh1 and protein isolated therefrom, concrete compositions, and uses thereof |
| 05/12/2011 | WO2011054995A2 PROPHYLACTIC FLU VACCINES FROM VIRAL CAPSIDS OF BIRNAVIRUS CONTAINING THE M2e ANTIGEN OF THE FLU VIRUS |
| 05/12/2011 | WO2011054690A1 Stabilization of bio-sensors for in vivo applications |
| 05/12/2011 | WO2011054644A1 A low density lipoprotein-related protein 1 splice variant as cancer marker |
| 05/12/2011 | WO2011054519A1 Glycosylated repeat-motif-molecule conjugates |
| 05/12/2011 | WO2011035202A3 Universal fibronectin type iii binding-domain libraries |
| 05/12/2011 | WO2011011347A3 Functionalization of silk material by avidin-biotin interaction |
| 05/12/2011 | WO2011010337A9 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 05/12/2011 | WO2010151517A3 Antigen-specific long-term memory t-cells |
| 05/12/2011 | WO2010150982A9 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
| 05/12/2011 | WO2010150233A3 Multimeric polypeptides of hla-g including at least two alpha3 domains and pharmaceutical uses thereof |
| 05/12/2011 | WO2010108245A3 Use of leishmania antigens in a diagnostic method, vaccine and therapy for leishmaniasis |
| 05/12/2011 | US20110113507 Tomatoes That Soften More Slowly Post-Harvest Due To Non-Transgenic Alterations In An Expansin Gene |
| 05/12/2011 | US20110113495 Screening method for agents suitable for prophylaxis and therapy of alzheimer's disease (ad) |
| 05/12/2011 | US20110112990 Efficient Production of Peptides |
| 05/12/2011 | US20110112280 Use of rgm and its modulators |
| 05/12/2011 | US20110112278 Novel tumor marker for pancreatic cancer |
| 05/12/2011 | US20110112277 Stabilized Polymeric Thiol Reagents |
| 05/12/2011 | US20110112276 Mutated immunoglobulin-binding protein |
| 05/12/2011 | US20110112177 Human G-Protein Coupled Receptor (HETGQ23) |
| 05/12/2011 | US20110112172 SDF-1 Binding Nucleic Acids |
| 05/12/2011 | US20110112040 Supercharged proteins for cell penetration |
| 05/12/2011 | US20110112037 Crystal structure |
| 05/12/2011 | US20110112031 Optimized dengue virus entry inhibitory peptide (dn81) |
| 05/12/2011 | US20110112022 Factor VIII Muteins with Reduced Immonugenicity |
| 05/12/2011 | US20110112021 Pegylated recombinant human growth hormone compounds |
| 05/12/2011 | US20110112018 Method for the Treatment and/or Prophylaxis of Multiple Sclerosis, and Use of Erythropoietin for the Manufacture of a Medicament for the Intermittent and/or Intermittent Prophylaxis of Multiple Sclerosis |
| 05/12/2011 | US20110112015 Use of glis3 for preparing functional pancreatic beta-cells |
| 05/12/2011 | US20110112013 Novel Bacillus thuringiensis Gene with Lepidopteran Activity |
| 05/12/2011 | US20110112012 Novel Protein for Binding Bacillus Thuringiensis Cry Toxins and Fragments of Cadherins for Enhancing Cry Toxicity Against Dipterans |
| 05/12/2011 | US20110111979 Prostate Cancer-Related Compositions, Methods and Kits Based on DNA Microarray Proteomics Platforms |
| 05/12/2011 | US20110111528 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 05/12/2011 | US20110111505 Genetically engineered cells which express bone morphogenic proteins |
| 05/12/2011 | US20110111482 High Viscosity Xanthan Polymer Preparations |
| 05/12/2011 | US20110111477 Long acting formulation of biopharmaceutical |
| 05/12/2011 | US20110111455 Polymer-Von Willebrand Factor-Conjugates |
| 05/12/2011 | US20110111445 Peptide for Determining Actin Structures in Living Cells |
| 05/12/2011 | US20110111444 Method of Screening for Compounds which Affect the Processing of EphA4 by Gamma-Secretase |
| 05/12/2011 | US20110111439 Elevation of Induced Heat Shock Proteins in Patient's Cerebral Spinal Fluid: A Biomarker of Risk/Onset of Ischemia and/or Paralysis in Aortic Surgery |
| 05/12/2011 | US20110111422 Sensor proteins and assay methods |
| 05/12/2011 | US20110111391 Newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |
| 05/12/2011 | US20110111043 Peptides and their use as carriers into cancer cells |
| 05/12/2011 | US20110111023 Prevention of type 1 diabetes by administration of gliadin |
| 05/12/2011 | US20110111003 Stable cell binding chimeric peptides |
| 05/12/2011 | US20110110976 Rift valley fever virus-like particles and their use for immunization and as test system |
| 05/12/2011 | US20110110973 Influenza B Vaccines |
| 05/12/2011 | US20110110970 Chimeric vaccines |
| 05/12/2011 | US20110110969 Peptide vaccines against group a streptococci |
| 05/12/2011 | US20110110967 Gas57 mutant antigens and gas57 antibodies |
| 05/12/2011 | US20110110966 Novel immunogenic proteins of leptospira |
| 05/12/2011 | US20110110965 Compositions that induce t cell help |
| 05/12/2011 | US20110110963 Gene encoding labyrinthin, a marker for cancer |
| 05/12/2011 | US20110110962 Novel Immunoadjuvant Flagellin-Based Compounds and Use Thereof |
| 05/12/2011 | US20110110959 Anti-p2x7 peptides and epitopes |
| 05/12/2011 | US20110110955 Antibody cancer immunotherapy |
| 05/12/2011 | US20110110954 Anthrax compositions and methods of use and production |
| 05/12/2011 | US20110110952 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 05/12/2011 | US20110110951 Isolation of five novel genes coding for new fc receoptrs-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/12/2011 | US20110110947 Viral chemokine-antigen fusion proteins |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110934 Treatment of uveitis |
| 05/12/2011 | US20110110926 Compositions and methods for treating or preventing prostate cancer and for detecting androgen receptor variants |
| 05/12/2011 | US20110110922 Wound Healing Peptides and Methods of Use Thereof |
| 05/12/2011 | US20110110917 Human Aminoacyl-tRNA Synthetase Polypeptides Useful For The Regulation of Angiogenesis |
| 05/12/2011 | US20110110866 Elastin-like polypeptide and gadolinium conjugate for magnetic resonance imaging |
| 05/12/2011 | US20110110861 Methods of Detecting Cells with a Disrupted Cell Membrane, Cells Infected with A Pathogen, Dying Cells or Dead Cells |
| 05/12/2011 | US20110110857 Mutant forms of chlamydia htra |
| 05/12/2011 | US20110110856 Optimized Adhesin Fragments And Corresponding Nanoparticles |
| 05/12/2011 | US20110110855 Novel ghrelin analogues |
| 05/12/2011 | US20110110854 Methods and Compositions for Improved F-18 Labeling of Proteins, Peptides and Other Molecules |
| 05/12/2011 | US20110108420 Methods for production of proteins |
| 05/12/2011 | CA2780163A1 Method for treating heart failure with stresscopin-like peptides |
| 05/12/2011 | CA2779839A1 T-cell stimulating protein b and methods of use |
| 05/12/2011 | CA2779688A1 Quantitation of insulin-like growth factor-i and insulin-like growth factor-ii with high-resolution mass spectrometry |
| 05/12/2011 | CA2779645A1 Vaccines for the treatment of neoplasias based on viral capsids of birnavirus containing human papillomavirus antigens |
| 05/12/2011 | CA2779632A1 Simian adenovirus and methods of use |
| 05/12/2011 | CA2779526A1 Truncated epiderimal growth factor receptor (egfrt) for transduced t cell selection |
| 05/12/2011 | CA2779515A1 Haemophilus parasuis polypeptides and methods of use |
| 05/12/2011 | CA2779482A1 Treatments for gastrointestinal disorders |
| 05/12/2011 | CA2778361A1 Stabilization of bio-sensors for in vivo applications |
| 05/12/2011 | CA2778234A1 Methods and compositions for modulating tau levels |
| 05/12/2011 | CA2778203A1 Glycosylated repeat-motif-molecule conjugates |
| 05/11/2011 | EP2320233A1 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 05/11/2011 | EP2319935A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319934A2 GnTIII (UDP-N-acetylglucosamine:Beta -D mannoside Beta (1,4)-N-acetylglucosaminyltransferase III) expression in plants |
| 05/11/2011 | EP2319931A1 Extracellular matrix-binding proteins from staphylococcus aureus |
| 05/11/2011 | EP2319930A1 Genes, proteins and vectors for increaseing tolerance of plants and microbes to abiotic stresses and the use thereof |
| 05/11/2011 | EP2319929A1 IL-1 related polypeptides |
| 05/11/2011 | EP2319928A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 05/11/2011 | EP2319927A1 Secretion expression of antibiotic peptide cad in bacillus subtilis and expression system of recombination bacillus subtilis |
| 05/11/2011 | EP2319924A1 Polypeptide marker for diagnosis of arteriosclerosis, method for detection of arteriosclerosis by using the maker or the like, and kit for diagnosis of arteriosclerosis |
| 05/11/2011 | EP2319917A2 Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 05/11/2011 | EP2319868A1 Immunotherapeutic treatment for inducing the regression of atherosclerotic plaques |
| 05/11/2011 | EP2319866A2 Polymorphisms in the human genes for OCT1 and their use in diagnostic and therapeutic applications |
| 05/11/2011 | EP2319865A1 Nucleophosmin protein (NPM) mutants, corresponding gene sequences and uses thereof |
| 05/11/2011 | EP2319864A2 Nematoden als Modellorganismen zur Untersuchung neurodegenerativer Erkrankungen und insbesonder der parkinsonschen Erkrankung, Verwendung und Verfahren |
| 05/11/2011 | EP2319863A1 Lactobacillus acidophilus nucleic acids encoding fructo-oligosaccharide utilization compounds and uses thereof |